Christopher Lowe
Unternehmenssekretär bei BIOASIS TECHNOLOGIES INC.
Ursprung des Netzwerks ersten Grades von Christopher Lowe
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 19 | |
Public Company | Pharmaceuticals: Major | 17 | |
Public Company | Biotechnology | 16 | |
Public Company | Pharmaceuticals: Major | 13 | |
Subsidiary | Medical Specialties | 12 | |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
9
| Extinct | Miscellaneous Commercial Services | 9 |
Public Company | Biotechnology | 9 | |
American Standard Cos., Inc.
6
| Extinct | Industrial Machinery | 6 |
Nusano, Inc.
Nusano, Inc. Medical SpecialtiesHealth Technology Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022.
5
| Holding Company | Medical Specialties | 5 |
Asthmatx, Inc.
Asthmatx, Inc. Medical SpecialtiesHealth Technology Asthmatx, Inc. develops catheter-based outpatient procedure that provides asthma control for adult severe asthma patients. The company was founded in 2003 and is headquartered in Sunnyvale, CA.
4
| Extinct | Medical Specialties | 4 |
FLG Partners LLC
FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith.
3
| Private Company | Miscellaneous Commercial Services | 3 |
SentreHEART, Inc.
SentreHEART, Inc. Medical SpecialtiesHealth Technology SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.
2
| Extinct | Medical Specialties | 2 |
Subsidiary | Medical Specialties | 2 | |
Pacific Pharmaceutical Services LLC
Pacific Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Pacific Pharmaceutical Services LLC provides virtual pharmaceutical development and warehousing services. The company is based in Reno, NV.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christopher Lowe
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Davis | College/University | Graduate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Purdue University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
University of British Columbia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
INVUITY INC | Medical Distributors | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Pacira CryoTech, Inc.
Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Medical/Nursing Services | Chairman Chief Executive Officer Director of Finance/CFO | |
Corthera, Inc.
Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
University of Vermont | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of California | College/University | Director/Board Member Doctorate Degree Masters Business Admin | |
Pepperdine University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of California, Santa Barbara | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | President Director/Board Member Corporate Officer/Principal | |
EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal General Counsel | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal | |
University of Warwick | College/University | Undergraduate Degree Doctorate Degree | |
University of Wyoming | College/University | Graduate Degree Undergraduate Degree | |
Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
AFFYMAX, INC. | Biotechnology | Director/Board Member General Counsel | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
eCharge Corp.
eCharge Corp. Miscellaneous Commercial ServicesCommercial Services eCharge Corp. provides secure online payment services. The American company was founded by Robin Bruce Hutchison and George Fleming. The CEO is Truett Tate. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
RELYPSA INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
The University of North Carolina at Charlotte | College/University | Graduate Degree Doctorate Degree | |
IMMUNITYBIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Graduate Degree Doctorate Degree | |
CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
CannÖgen International, Inc.
CannÖgen International, Inc. Pharmaceuticals: OtherHealth Technology CannÖgen International, Inc. engages in the development, production, marketing, and sale of science-based health products to address a broad spectrum of physical conditions. Its product lines are health composition products, pH beverage products, medical food compositions, and pet health products. The company was founded on March 30, 2021 and is headquartered in White Rock, Canada. | Pharmaceuticals: Other | Director/Board Member Chairman |
Statistik
International
Vereinigte Staaten | 47 |
Kanada | 4 |
Vereinigtes Königreich | 2 |
Sektoral
Consumer Services | 23 |
Health Technology | 23 |
Commercial Services | 4 |
Distribution Services | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 417 |
Corporate Officer/Principal | 219 |
Independent Dir/Board Member | 130 |
Chairman | 95 |
Undergraduate Degree | 85 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Richard Ferrari | 43 |
Peter Thompson | 39 |
Bo Jesper Hansen | 34 |
David Wurzer | 31 |
Michael Pellini | 31 |
Karen Smith | 29 |
Dennis Podlesak | 27 |
Ronald Erickson | 27 |
Dan Spiegelman | 24 |
Marjorie Bowen | 24 |
Lowell E. Sears | 22 |
Sanford Zweifach | 22 |
Donald Santel | 20 |
Andrew McDonald | 19 |
Sandra Gardiner | 19 |
- Börse
- Insiders
- Christopher Lowe
- Unternehmensverbindungen